ZLAB Earnings
Zai Lab Ltd
$
36.600
- Overview
- Forecast
- Valuation
- Earnings
Earning Analysis
Welcome to our in-depth analysis of Zai Lab Ltd(ZLAB) earnings, offering investors a detailed look into the company’s financial performance, revenue trends, earnings per share (EPS), and market reactions. This page provides a comprehensive overview of Zai Lab Ltd earnings history, forecasts, and key financial metrics, empowering you with the data needed to make informed investment decisions. Whether you're tracking quarterly results, analyzing earnings surprises, or exploring future projections, our detailed breakdown covers it all.
Earnings Forecast
Revenue
EPS
Currency: USD
Actual
Estimate
Surprise Analysis
| FY2025Q2 | 2025-08-07 | Pre-Market | -0.37 | - | - | 127.70M | - | - | - | - |
| FY2025Q1 | 2025-05-08 | Pre-Market | -0.50 | -0.45 | +10.00 | 115.86M | 106.49M | -8.09 | +2.75 | +0.92 |
| FY2024Q4 | 2025-02-27 | Pre-Market | -0.61 | -0.80 | -31.15 | 110.15M | 109.07M | -0.98 | -1.97 | +2.40 |
| FY2024Q2 | 2024-08-06 | - | -0.66 | -0.82 | -24.24 | 93.14M | 100.50M | +7.91 | +2.66 | -7.77 |
| FY2024Q1 | 2024-05-08 | - | -0.93 | -0.55 | +40.86 | 75.24M | 87.15M | +15.83 | -0.66 | +29.20 |
| FY2023Q4 | 2024-02-27 | - | -0.87 | -0.98 | -12.64 | 72.10M | 65.83M | -8.70 | +7.15 | -2.72 |
| FY2023Q3 | 2023-11-07 | - | -0.94 | -0.71 | +24.47 | 66.67M | 69.23M | +3.84 | +1.36 | -3.19 |
| FY2023Q2 | 2023-08-07 | - | -0.74 | -1.25 | -68.92 | 70.67M | 68.86M | -2.56 | -2.86 | -5.36 |
| - | 2023-05-09 | - | -0.94 | -0.51 | +45.74 | - | - | - | -4.43 | -9.05 |
| - | 2023-03-01 | - | -1.04 | -0.65 | +37.50 | - | - | - | +8.69 | +2.83 |
ZLAB Earnings Analysis
Our earnings analysis provides a granular look at the company’s performance across recent fiscal quarters, highlighting key metrics such as revenue, EPS, and operating margins. By examining actual results against analyst estimates, we uncover trends and surprises that drive stock price movements, offering valuable insights for both short-term traders and long-term investors.
In the most recent quarter, Zai Lab Ltd reported performance for FY2025Q2, announced on 2025-08-07. The company achieved an EPS of , compared to analyst estimates of -0.37 by % . Revenue for the quarter reached 0.00 compared to expectations of 127.70M by % .
The stock price reacted with a % one-day change and a % five-day change following the earnings release. These movements reflect market reaction in Zai Lab Ltd growth trajectory and strategic initiatives.
ZLAB Earnings Forecast
Looking ahead, Zai Lab Ltd(ZLAB) remains a focal point for investors seeking growth opportunities. Analyst forecasts for 2025/Q2 project quarter revenue of 125.02M and an EPS of -0.42.
However, recent estimate revisions provide additional context. Over the past three months, revenue estimates for FY2025 have been Revise Upward by 0.46%, while EPS estimates have been Revise Downward by -12.17%. For the upcoming Q2 2025, revenue estimates have been adjusted Revise Downward by -2.69% . These revisions correlate with a 17.50% change in stock price over the same period, suggesting potential buying opportunities for investors who believe in Zai Lab Ltd long-term fundamentals.
The relationship between earnings forecast revisions and stock price movements is critical for investors. Positive revisions in revenue or EPS often signal strengthening fundamentals, making temporary price dips attractive entry points. Conversely, downward revisions may reflect short-term challenges.
Estimate Revision
The chart shows the correlation between ZLAB's stock price and earnings forecast revisions. Positive revisions in Revenue or EPS often strengthen the stock's fundamentals, making price dips potential buying opportunities.
Revenue Estimates for FY2025
Revise Upward
+0.46%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
-12.17%
In Past 3 Month
Revenue Estimates for Q2 2025
Revise Downward
-2.69%
In Past 3 Month
Stock Price
Go Up
+17.50%
In Past 3 Month
1Y
3Y
5Y
Annual FY 2025
Currency: USD
1Y
3Y
5Y
--
Revenue Estimate-Annual FY 2025:567.74M
--
EPS Estimate-Annual FY 2025:-1.43
—
Stock Price36.60
ZLAB Revenue and EPS Performance: A Historical Perspective
Zai Lab Ltd revenue and earnings per share (EPS) performance over recent quarters provides a clear picture of its financial health. Below is a detailed breakdown of the company’s earnings history, showcasing actual results, analyst estimates, and surprise percentages for key fiscal quarters:
FY2025Q2 (2025-08-07,Pre-Market):
EPS: (Actual) vs.-0.37 (Estimate) (%)
Revenue: 0.00 (Actual) vs. 127.70M (Estimate) (%)
Price Reaction: %(1-Day), %(5-Day)
FY2025Q1 (2025-05-08,Pre-Market):
EPS: -0.45 (Actual) vs.-0.50 (Estimate) (10.00%)
Revenue: 106.49M (Actual) vs. 115.86M (Estimate) (-8.09%)
Price Reaction: 2.75%(1-Day), 0.92%(5-Day)
FY2024Q4 (2025-02-27,Pre-Market):
EPS: -0.80 (Actual) vs.-0.61 (Estimate) (-31.15%)
Revenue: 109.07M (Actual) vs. 110.15M (Estimate) (-0.98%)
Price Reaction: -1.97%(1-Day), 2.40%(5-Day)
Earnings Reaction
The chart below shows how ZLAB performed 10 days before and after its earnings report, based on data from the past quarters. Typically, ZLAB sees a -2.62% change in stock price 10 days leading up to the earnings, and a -2.16% change 10 days following the report. On the earnings day itself, the stock moves by +1.41%. This data can give you a slight idea of what to expect for the next quarter's release.
For example, in MAR/2025, the stock changed 0.34% on the day following the earnings release and then changed by 11.53% over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.
Transcript Summary
Zai Lab Ltd (ZLAB) Q4 2024 Earnings Call Summary
Positive
2025-02-27
The earnings call revealed strong financial performance with a 66% increase in Q4 revenue and a 50% increase for the year, primarily driven by VYVGART's successful launch. The company is on track for profitability by Q4 2025, with a robust cash position supporting growth. Despite some uncertainties in clinical trials and market penetration challenges, optimistic guidance and growth prospects for other products like ZEJULA and NUZYRA contribute to a positive outlook. Given the market cap, a positive stock price movement of 2% to 8% is expected.
Zai Lab Limited (ZLAB) Q3 2024 Earnings Call Summary
Positive
2024-11-12
The earnings call summary shows strong revenue growth, particularly with VYVGART, and a significant improvement in net loss. The raised guidance for VYVGART and the strategic focus on profitability by 2025 are positive indicators. Despite some risks, such as regulatory challenges and competitive pressures, the overall sentiment is positive. The Q&A section supports this with expectations of continued growth and a favorable competitive landscape for KarXT. The company's market cap suggests a moderate reaction, leading to a prediction of a positive stock price movement of 2% to 8%.
Zai Lab Limited (ZLAB) Q2 2024 Earnings Call Summary
Positive
2024-08-07
The earnings call highlights several positive aspects: a 45% YoY revenue increase, significant product growth, reduced net loss, and strong cash position. The guidance for profitability by 2025 and expectations of regulatory approvals further boost sentiment. Despite competitive pressures and supply chain risks, management's confidence in VYVGART's performance and strategic focus on oncology and immunology are reassuring. The market cap indicates moderate volatility, suggesting a positive stock price movement of 2% to 8% over the next two weeks.
People Also Watch
LUNR
Intuitive Machines Inc
10.630
USD
-4.75%
NVCR
Novocure Ltd
11.255
USD
-2.72%
AWR
American States Water Co
74.970
USD
+1.88%
BOH
Bank of Hawaii Corp
61.290
USD
-0.95%
CPK
Chesapeake Utilities Corp
119.530
USD
-0.29%
DIOD
Diodes Inc
49.190
USD
-0.36%
TWST
Twist Bioscience Corp
33.410
USD
-0.48%
LAUR
Laureate Education Inc
22.770
USD
+0.75%
INDB
Independent Bank Corp (Massachusetts)
62.240
USD
-2.06%
FAQ
What were the key highlights of ZLAB’s latest earnings report for FY2025Q2?
ZLAB reported its FY2025Q2 earnings on 2025-08-07, showcasing a revenue of 0.00 against an estimate of 127.70M, resulting in a 0% surprise. The EPS was 0, surpassing the expected -0.37 by 0% . The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.
How did ZLAB’s stock price react after the FY2025Q2 earnings release?
What are the revenue and EPS estimates for ZLAB for 2025/Q2?
How does ZLAB’s stock price correlate with earnings forecast revisions?
What should investors expect from ZLAB’s next earnings report?